| Study of Efficacy, Cycle Control, and Safety of a NES-E2 Contraceptive Vaginal Ring (NCT03432416) | Premier Research | 2018-02-12 |
| Compare Two Copper IUDs: Mona Lisa NT Cu380 Mini and ParaGard (NCT03124160) | FHI 360 | 2017-05-26 |
| Descriptive, Prospective, Non-interventional Study (NIS) to Describe Mirena and Amenorrhea Related Acceptability in Contraception Indication in Medical Practice (NCT01833793) | Bayer | 2013-02-01 |
| Oral Contraceptives and Economic Behaviour (NCT02257671) | Karolinska University Hospital | 2012-02-01 |
| Prevention of Ovulation Achieved by Single Intra-vaginal Administration of Levogel as Compared to Oral LNG (NCT01286948) | Population Council | 2011-01-01 |
| A Study to Evaluate the Efficacy and Safety of DR-102 for the Prevention of Pregnancy (NCT01178125) | Teva Branded Pharmaceutical Products R&D, Inc. | 2010-08-01 |
| Relative Risks for Non-fatal Venous Thromboembolism, Ischemic Stroke and Myocardial Infarction in Users of ORTHO EVRA(Norelgestromin and Ethinyl Estradiol Contraceptive Patch) Compared to Levonorgestrel-containing Oral Contraceptives. (NCT00511784) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2006-11-01 |
| Bioequivalence Study of the Oral Contraceptive Tablet Containing Norgestimate (NGM)/Ethinyl Estradiol (EE) With or Without Folic Acid in Healthy Women. (NCT00709189) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2005-05-01 |
| Bioequivalence Study of Patches With Different Equilibration Profiles (NCT00775086) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2004-05-01 |
| A Study to Evaluate the Hormone Exposure From Multiple Commercial Lots of ORTHO EVRA (a Transdermal Contraceptive Patch) (NCT00258076) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2004-04-01 |
| Evaluation of Women's Experience With EVRA (Norelgestromin + Ethinyl Estradiol) Transdermal Contraceptive Patch Compared With Previous Methods of Contraception. (NCT00261482) | Janssen Pharmaceutica N.V., Belgium | 2003-07-01 |
| Bioequivalence Study of Patches With Different Release Profiles (NCT00697307) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2003-03-01 |
| An Open-label, Multicentre Study on Preference and Satisfaction of Canadian Women for the Transdermal Contraceptive Patch vs. Previous Primary Contraceptive Method (NCT00653016) | Janssen-Ortho Inc., Canada | 2002-10-01 |
| A Comparative Pharmacokinetic Study of ORTHO EVRA (a Transdermal Contraceptive Patch) and CILEST (an Oral Contraceptive) in Healthy Female Volunteers (NCT00254865) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2002-08-01 |
| Postmarketing Study of ORTHO EVRA (Norelgestromin and Ethinyl Estradiol Contraceptive Patch) in Relation to Venous Thromboembolism (Blood Clots), Stroke and Heart Attacks (NCT00331071) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2002-04-01 |
| A Postmarketing Study of the Risk of Venous Thromboembolism (Blood Clots), Myocardial Infarction (Heart Attacks), and Stroke Among Women Using ORTHO EVRA (Norelgestromin and Ethinyl Estradiol Contraceptive Patch) Compared With Women Who Take Oral Contraceptives for Birth Control (NCT00377988) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2002-04-01 |
| A Study of Efficacy and Safety With the Transdermal Contraceptive System. (NCT00236769) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 1997-11-01 |
| A Study of Efficacy and Safety With the Transdermal Contraceptive System Versus Triphasil. (NCT00236795) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 1997-01-01 |